ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 90 filers reported holding ONCOCYTE CORP in Q1 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $47,000 | -83.4% | 21,542 | -72.9% | 0.00% | -100.0% |
| Q3 2021 | $283,000 | -28.7% | 79,429 | +14.9% | 0.00% | -50.0% |
| Q2 2021 | $397,000 | -7.0% | 69,123 | -16.0% | 0.00% | -33.3% |
| Q1 2021 | $427,000 | +941.5% | 82,277 | +284.9% | 0.00% | +200.0% |
| Q2 2020 | $41,000 | +57.7% | 21,377 | +98.3% | 0.00% | 0.0% |
| Q1 2020 | $26,000 | – | 10,778 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 1,093,219 | $6,833,000 | 1.15% |
| HUNTINGTON NATIONAL BANK | 10 | $0 | 0.00% |
| CITIGROUP INC | 642 | $4,000 | 0.00% |
| Sonora Investment Management, LLC | 50 | $0 | 0.00% |
| BARCLAYS PLC | 206 | $1,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 96 | $1,000 | 0.00% |